Above: Roche – One Of The Largest Pharmaceutical Companies In The World.
Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology, and neuroscience.
Roche has one of the largest, most promising pipelines in the pharmaceutical industry. Cancer medicine spending reached $107 billion last year, and by 2020, is expected to pass $150 billion. Roche is a cancer powerhouse with about $25 billion in oncology sales alone during 2015.
One reason Roche’s existing cancer therapies have performed so well is because of Roche’s early adoption of personalized medicine, the science of tailoring treatments to a myriad of genetically defined patient groups. Its diagnostics division, which recorded approximately $11 billion in sales in 2015, provides a level of insight unmatched by its peers.
The Roche Dividend
Roche has raised the annual distribution (dividend), in Swiss Francs, for 29 consecutive years, and is poised to continue doing so for many more years. That makes Roche stock a true blue chip stock that you could buy and probably hold forever.
Roche Yearly Dividend Payments | Roche Dividend History (Yearly)